Telesis Bio, Inc.
TBIO
$0.42
$0.1240.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -32.97M | -36.96M | -36.96M | -39.44M | -29.88M |
| Total Depreciation and Amortization | 3.12M | 3.24M | 3.24M | 3.20M | 2.93M |
| Total Amortization of Deferred Charges | 160.00K | 610.00K | 610.00K | 653.00K | 681.00K |
| Total Other Non-Cash Items | 14.76M | 15.91M | 15.91M | 16.03M | 4.45M |
| Change in Net Operating Assets | -2.58M | 774.00K | 774.00K | -4.80M | -852.00K |
| Cash from Operations | -17.51M | -16.42M | -26.72M | -34.65M | -32.98M |
| Capital Expenditure | -809.00K | -828.00K | -828.00K | -796.00K | -1.31M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.00M | -3.65M | -3.65M | -11.81M | -6.59M |
| Cash from Investing | 23.19M | -4.48M | 2.37M | -5.76M | -1.05M |
| Total Debt Issued | 5.67M | -- | -- | -- | 0.00 |
| Total Debt Repaid | -20.09M | -15.08M | -15.08M | -15.09M | -59.00K |
| Issuance of Common Stock | 35.00K | 60.00K | 60.00K | 68.00K | 184.00K |
| Repurchase of Common Stock | -12.00K | -12.00K | -12.00K | -- | -- |
| Issuance of Preferred Stock | 1.00M | 1.00M | 1.00M | 1.00M | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.82M | -1.12M | -1.12M | -1.12M | -136.00K |
| Cash from Financing | -15.22M | -15.15M | 11.56M | 11.57M | 26.69M |
| Foreign Exchange rate Adjustments | 11.00K | -9.00K | -9.00K | -3.00K | -16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.52M | -36.06M | -12.81M | -28.85M | -7.35M |
